Respiratory syncytial virus (RSV) is a highly contagious virus that primarily affects the respiratory tract (lungs and breathing passages). It is a common cause of upper and lower respiratory infections in infants, young children, and elderly people. The infection can lead to severe complications such as pneumonia and bronchiolitis.

The global market for Respiratory Syncytial Virus Diagnostic Testing was estimated to be worth US$ million in 2023 and is forecast to a readjusted size of US$ million by 2030 with a CAGR of % during the forecast period 2024-2030.

The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Respiratory Syncytial Virus Diagnostic Testing, focusing on the total sales revenue, key companies market share and ranking, together with an analysis of Respiratory Syncytial Virus Diagnostic Testing by region & country, by Type, and by Application.

The Respiratory Syncytial Virus Diagnostic Testing market size, estimations, and forecasts are provided in terms of sales revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Respiratory Syncytial Virus Diagnostic Testing.

Market Segmentation

Scope of Respiratory Syncytial Virus Diagnostic Testing - Market Report

Report Metric	Details
Report Name	Respiratory Syncytial Virus Diagnostic Testing - Market
CAGR	5%
Segment by Type:	Antigen Detection Test Molecular Diagnostic Test Direct Fluorescent Antibody Test Diagnostic Imaging Others
Segment by Application	Hospitals Diagnostic Laboratories Others
By Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Rest of Europe Nordic Countries Asia-Pacific (China, Japan, South Korea) Southeast Asia (India, Australia) Rest of Asia Latin America (Mexico, Brazil) Rest of Latin America Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company	F. Hoffmann-La Roche AG, Abbott, Thermo Fisher Scientific, BD (Becton, Dickinson and Company), QuidelOrtho Corporation, Hologic, Inc., Luminex Corporation, Agilent Technologies, Inc., Cepheid (Danaher Corporation), DiaSorin S.p.A.
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Introduces the report scope of the report, global total market size. This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 2: Detailed analysis of Respiratory Syncytial Virus Diagnostic Testing manufacturers competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Revenue of Respiratory Syncytial Virus Diagnostic Testing in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 6: Revenue of Respiratory Syncytial Virus Diagnostic Testing in country level. It provides sigmate data by Type, and by Application for each country/region.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product revenue, gross margin, product introduction, recent development, etc.
Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 9: Conclusion.

FAQ for this report

Who are the main players in the Respiratory Syncytial Virus Diagnostic Testing - Market report?

Ans: The main players in the Respiratory Syncytial Virus Diagnostic Testing - Market are F. Hoffmann-La Roche AG, Abbott, Thermo Fisher Scientific, BD (Becton, Dickinson and Company), QuidelOrtho Corporation, Hologic, Inc., Luminex Corporation, Agilent Technologies, Inc., Cepheid (Danaher Corporation), DiaSorin S.p.A.

What are the Application segmentation covered in the Respiratory Syncytial Virus Diagnostic Testing - Market report?

Ans: The Applications covered in the Respiratory Syncytial Virus Diagnostic Testing - Market report are Hospitals, Diagnostic Laboratories, Others

What are the Type segmentation covered in the Respiratory Syncytial Virus Diagnostic Testing - Market report?

Ans: The Types covered in the Respiratory Syncytial Virus Diagnostic Testing - Market report are Antigen Detection Test, Molecular Diagnostic Test, Direct Fluorescent Antibody Test, Diagnostic Imaging, Others

1 Market Overview

1.1 Respiratory Syncytial Virus Diagnostic Testing Product Introduction

1.2 Global Respiratory Syncytial Virus Diagnostic Testing Market Size Forecast

1.3 Respiratory Syncytial Virus Diagnostic Testing Market Trends & Drivers

1.3.1 Respiratory Syncytial Virus Diagnostic Testing Industry Trends

1.3.2 Respiratory Syncytial Virus Diagnostic Testing Market Drivers & Opportunity

1.3.3 Respiratory Syncytial Virus Diagnostic Testing Market Challenges

1.3.4 Respiratory Syncytial Virus Diagnostic Testing Market Restraints

1.4 Assumptions and Limitations

1.5 Study Objectives

1.6 Years Considered

2 Competitive Analysis by Company

2.1 Global Respiratory Syncytial Virus Diagnostic Testing Players Revenue Ranking (2023)

2.2 Global Respiratory Syncytial Virus Diagnostic Testing Revenue by Company (2019-2024)

2.3 Key Companies Respiratory Syncytial Virus Diagnostic Testing Manufacturing Base Distribution and Headquarters

2.4 Key Companies Respiratory Syncytial Virus Diagnostic Testing Product Offered

2.5 Key Companies Time to Begin Mass Production of Respiratory Syncytial Virus Diagnostic Testing

2.6 Respiratory Syncytial Virus Diagnostic Testing Market Competitive Analysis

2.6.1 Respiratory Syncytial Virus Diagnostic Testing Market Concentration Rate (2019-2024)

2.6.2 Global 5 and 10 Largest Companies by Respiratory Syncytial Virus Diagnostic Testing Revenue in 2023

2.6.3 Global Top Companies by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Respiratory Syncytial Virus Diagnostic Testing as of 2023)

2.7 Mergers & Acquisitions, Expansion

3 Segmentation by Type

3.1 Introduction by Type

3.1.1 Antigen Detection Test

3.1.2 Molecular Diagnostic Test

3.1.3 Direct Fluorescent Antibody Test

3.1.4 Diagnostic Imaging

3.1.5 Others

3.2 Global Respiratory Syncytial Virus Diagnostic Testing Sales Value by Type

3.2.1 Global Respiratory Syncytial Virus Diagnostic Testing Sales Value by Type (2019 VS 2023 VS 2030)

3.2.2 Global Respiratory Syncytial Virus Diagnostic Testing Sales Value, by Type (2019-2030)

3.2.3 Global Respiratory Syncytial Virus Diagnostic Testing Sales Value, by Type (%) (2019-2030)

4 Segmentation by Application

4.1 Introduction by Application

4.1.1 Hospitals

4.1.2 Diagnostic Laboratories

4.1.3 Others

4.2 Global Respiratory Syncytial Virus Diagnostic Testing Sales Value by Application

4.2.1 Global Respiratory Syncytial Virus Diagnostic Testing Sales Value by Application (2019 VS 2023 VS 2030)

4.2.2 Global Respiratory Syncytial Virus Diagnostic Testing Sales Value, by Application (2019-2030)

4.2.3 Global Respiratory Syncytial Virus Diagnostic Testing Sales Value, by Application (%) (2019-2030)

5 Segmentation by Region

5.1 Global Respiratory Syncytial Virus Diagnostic Testing Sales Value by Region

5.1.1 Global Respiratory Syncytial Virus Diagnostic Testing Sales Value by Region: 2019 VS 2023 VS 2030

5.1.2 Global Respiratory Syncytial Virus Diagnostic Testing Sales Value by Region (2019-2024)

5.1.3 Global Respiratory Syncytial Virus Diagnostic Testing Sales Value by Region (2025-2030)

5.1.4 Global Respiratory Syncytial Virus Diagnostic Testing Sales Value by Region (%), (2019-2030)

5.2 North America

5.2.1 North America Respiratory Syncytial Virus Diagnostic Testing Sales Value, 2019-2030

5.2.2 North America Respiratory Syncytial Virus Diagnostic Testing Sales Value by Country (%), 2023 VS 2030

5.3 Europe

5.3.1 Europe Respiratory Syncytial Virus Diagnostic Testing Sales Value, 2019-2030

5.3.2 Europe Respiratory Syncytial Virus Diagnostic Testing Sales Value by Country (%), 2023 VS 2030

5.4 Asia Pacific

5.4.1 Asia Pacific Respiratory Syncytial Virus Diagnostic Testing Sales Value, 2019-2030

5.4.2 Asia Pacific Respiratory Syncytial Virus Diagnostic Testing Sales Value by Country (%), 2023 VS 2030

5.5 South America

5.5.1 South America Respiratory Syncytial Virus Diagnostic Testing Sales Value, 2019-2030

5.5.2 South America Respiratory Syncytial Virus Diagnostic Testing Sales Value by Country (%), 2023 VS 2030

5.6 Middle East & Africa

5.6.1 Middle East & Africa Respiratory Syncytial Virus Diagnostic Testing Sales Value, 2019-2030

5.6.2 Middle East & Africa Respiratory Syncytial Virus Diagnostic Testing Sales Value by Country (%), 2023 VS 2030

6 Segmentation by Key Countries/Regions

6.1 Key Countries/Regions Respiratory Syncytial Virus Diagnostic Testing Sales Value Growth Trends, 2019 VS 2023 VS 2030

6.2 Key Countries/Regions Respiratory Syncytial Virus Diagnostic Testing Sales Value

6.3 United States

6.3.1 United States Respiratory Syncytial Virus Diagnostic Testing Sales Value, 2019-2030

6.3.2 United States Respiratory Syncytial Virus Diagnostic Testing Sales Value by Type (%), 2023 VS 2030

6.3.3 United States Respiratory Syncytial Virus Diagnostic Testing Sales Value by Application, 2023 VS 2030

6.4 Europe

6.4.1 Europe Respiratory Syncytial Virus Diagnostic Testing Sales Value, 2019-2030

6.4.2 Europe Respiratory Syncytial Virus Diagnostic Testing Sales Value by Type (%), 2023 VS 2030

6.4.3 Europe Respiratory Syncytial Virus Diagnostic Testing Sales Value by Application, 2023 VS 2030

6.5 China

6.5.1 China Respiratory Syncytial Virus Diagnostic Testing Sales Value, 2019-2030

6.5.2 China Respiratory Syncytial Virus Diagnostic Testing Sales Value by Type (%), 2023 VS 2030

6.5.3 China Respiratory Syncytial Virus Diagnostic Testing Sales Value by Application, 2023 VS 2030

6.6 Japan

6.6.1 Japan Respiratory Syncytial Virus Diagnostic Testing Sales Value, 2019-2030

6.6.2 Japan Respiratory Syncytial Virus Diagnostic Testing Sales Value by Type (%), 2023 VS 2030

6.6.3 Japan Respiratory Syncytial Virus Diagnostic Testing Sales Value by Application, 2023 VS 2030

6.7 South Korea

6.7.1 South Korea Respiratory Syncytial Virus Diagnostic Testing Sales Value, 2019-2030

6.7.2 South Korea Respiratory Syncytial Virus Diagnostic Testing Sales Value by Type (%), 2023 VS 2030

6.7.3 South Korea Respiratory Syncytial Virus Diagnostic Testing Sales Value by Application, 2023 VS 2030

6.8 Southeast Asia

6.8.1 Southeast Asia Respiratory Syncytial Virus Diagnostic Testing Sales Value, 2019-2030

6.8.2 Southeast Asia Respiratory Syncytial Virus Diagnostic Testing Sales Value by Type (%), 2023 VS 2030

6.8.3 Southeast Asia Respiratory Syncytial Virus Diagnostic Testing Sales Value by Application, 2023 VS 2030

6.9 India

6.9.1 India Respiratory Syncytial Virus Diagnostic Testing Sales Value, 2019-2030

6.9.2 India Respiratory Syncytial Virus Diagnostic Testing Sales Value by Type (%), 2023 VS 2030

6.9.3 India Respiratory Syncytial Virus Diagnostic Testing Sales Value by Application, 2023 VS 2030

7 Company Profiles

7.1 F. Hoffmann-La Roche AG

7.1.1 F. Hoffmann-La Roche AG Profile

7.1.2 F. Hoffmann-La Roche AG Main Business

7.1.3 F. Hoffmann-La Roche AG Respiratory Syncytial Virus Diagnostic Testing Products, Services and Solutions

7.1.4 F. Hoffmann-La Roche AG Respiratory Syncytial Virus Diagnostic Testing Revenue (US$ Million) & (2019-2024)

7.1.5 F. Hoffmann-La Roche AG Recent Developments

7.2 Abbott

7.2.1 Abbott Profile

7.2.2 Abbott Main Business

7.2.3 Abbott Respiratory Syncytial Virus Diagnostic Testing Products, Services and Solutions

7.2.4 Abbott Respiratory Syncytial Virus Diagnostic Testing Revenue (US$ Million) & (2019-2024)

7.2.5 Abbott Recent Developments

7.3 Thermo Fisher Scientific

7.3.1 Thermo Fisher Scientific Profile

7.3.2 Thermo Fisher Scientific Main Business

7.3.3 Thermo Fisher Scientific Respiratory Syncytial Virus Diagnostic Testing Products, Services and Solutions

7.3.4 Thermo Fisher Scientific Respiratory Syncytial Virus Diagnostic Testing Revenue (US$ Million) & (2019-2024)

7.3.5 BD (Becton, Dickinson and Company) Recent Developments

7.4 BD (Becton, Dickinson and Company)

7.4.1 BD (Becton, Dickinson and Company) Profile

7.4.2 BD (Becton, Dickinson and Company) Main Business

7.4.3 BD (Becton, Dickinson and Company) Respiratory Syncytial Virus Diagnostic Testing Products, Services and Solutions

7.4.4 BD (Becton, Dickinson and Company) Respiratory Syncytial Virus Diagnostic Testing Revenue (US$ Million) & (2019-2024)

7.4.5 BD (Becton, Dickinson and Company) Recent Developments

7.5 QuidelOrtho Corporation

7.5.1 QuidelOrtho Corporation Profile

7.5.2 QuidelOrtho Corporation Main Business

7.5.3 QuidelOrtho Corporation Respiratory Syncytial Virus Diagnostic Testing Products, Services and Solutions

7.5.4 QuidelOrtho Corporation Respiratory Syncytial Virus Diagnostic Testing Revenue (US$ Million) & (2019-2024)

7.5.5 QuidelOrtho Corporation Recent Developments

7.6 Hologic, Inc.

7.6.1 Hologic, Inc. Profile

7.6.2 Hologic, Inc. Main Business

7.6.3 Hologic, Inc. Respiratory Syncytial Virus Diagnostic Testing Products, Services and Solutions

7.6.4 Hologic, Inc. Respiratory Syncytial Virus Diagnostic Testing Revenue (US$ Million) & (2019-2024)

7.6.5 Hologic, Inc. Recent Developments

7.7 Luminex Corporation

7.7.1 Luminex Corporation Profile

7.7.2 Luminex Corporation Main Business

7.7.3 Luminex Corporation Respiratory Syncytial Virus Diagnostic Testing Products, Services and Solutions

7.7.4 Luminex Corporation Respiratory Syncytial Virus Diagnostic Testing Revenue (US$ Million) & (2019-2024)

7.7.5 Luminex Corporation Recent Developments

7.8 Agilent Technologies, Inc.

7.8.1 Agilent Technologies, Inc. Profile

7.8.2 Agilent Technologies, Inc. Main Business

7.8.3 Agilent Technologies, Inc. Respiratory Syncytial Virus Diagnostic Testing Products, Services and Solutions

7.8.4 Agilent Technologies, Inc. Respiratory Syncytial Virus Diagnostic Testing Revenue (US$ Million) & (2019-2024)

7.8.5 Agilent Technologies, Inc. Recent Developments

7.9 Cepheid (Danaher Corporation)

7.9.1 Cepheid (Danaher Corporation) Profile

7.9.2 Cepheid (Danaher Corporation) Main Business

7.9.3 Cepheid (Danaher Corporation) Respiratory Syncytial Virus Diagnostic Testing Products, Services and Solutions

7.9.4 Cepheid (Danaher Corporation) Respiratory Syncytial Virus Diagnostic Testing Revenue (US$ Million) & (2019-2024)

7.9.5 Cepheid (Danaher Corporation) Recent Developments

7.10 DiaSorin S.p.A.

7.10.1 DiaSorin S.p.A. Profile

7.10.2 DiaSorin S.p.A. Main Business

7.10.3 DiaSorin S.p.A. Respiratory Syncytial Virus Diagnostic Testing Products, Services and Solutions

7.10.4 DiaSorin S.p.A. Respiratory Syncytial Virus Diagnostic Testing Revenue (US$ Million) & (2019-2024)

7.10.5 DiaSorin S.p.A. Recent Developments

8 Industry Chain Analysis

8.1 Respiratory Syncytial Virus Diagnostic Testing Industrial Chain

8.2 Respiratory Syncytial Virus Diagnostic Testing Upstream Analysis

8.2.1 Key Raw Materials

8.2.2 Raw Materials Key Suppliers

8.2.3 Manufacturing Cost Structure

8.3 Midstream Analysis

8.4 Downstream Analysis (Customers Analysis)

8.5 Sales Model and Sales Channels

8.5.1 Respiratory Syncytial Virus Diagnostic Testing Sales Model

8.5.2 Sales Channel

8.5.3 Respiratory Syncytial Virus Diagnostic Testing Distributors

9 Research Findings and Conclusion

10 Appendix

10.1 Research Methodology

10.1.1 Methodology/Research Approach

10.1.2 Data Source

10.2 Author Details

10.3 Disclaimer

FEATURED COMPANIES

F. Hoffmann-La Roche AG

Abbott

Thermo Fisher Scientific

BD (Becton, Dickinson and Company)

QuidelOrtho Corporation

Hologic Inc

Luminex Corporation

Agilent Technologies Inc

Cepheid(Danaher Corporation)

DiaSorin

List of Tables

Table 1. Respiratory Syncytial Virus Diagnostic Testing Market Trends

Table 2. Respiratory Syncytial Virus Diagnostic Testing Market Drivers & Opportunity

Table 3. Respiratory Syncytial Virus Diagnostic Testing Market Challenges

Table 4. Respiratory Syncytial Virus Diagnostic Testing Market Restraints

Table 5. Global Respiratory Syncytial Virus Diagnostic Testing Revenue by Company (2019-2024) & (US$ Million)

Table 6. Global Respiratory Syncytial Virus Diagnostic Testing Revenue Market Share by Company (2019-2024)

Table 7. Key Companies Respiratory Syncytial Virus Diagnostic Testing Manufacturing Base Distribution and Headquarters

Table 8. Key Companies Respiratory Syncytial Virus Diagnostic Testing Product Type

Table 9. Key Companies Time to Begin Mass Production of Respiratory Syncytial Virus Diagnostic Testing

Table 10. Global Respiratory Syncytial Virus Diagnostic Testing Companies Market Concentration Ratio (CR5 and HHI)

Table 11. Global Top Companies Market Share by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Respiratory Syncytial Virus Diagnostic Testing as of 2023)

Table 12. Mergers & Acquisitions, Expansion Plans

Table 13. Global Respiratory Syncytial Virus Diagnostic Testing Sales Value by Type: 2019 VS 2023 VS 2030 (US$ Million)

Table 14. Global Respiratory Syncytial Virus Diagnostic Testing Sales Value by Type (2019-2024) & (US$ Million)

Table 15. Global Respiratory Syncytial Virus Diagnostic Testing Sales Value by Type (2025-2030) & (US$ Million)

Table 16. Global Respiratory Syncytial Virus Diagnostic Testing Sales Market Share in Value by Type (2019-2024) & (%)

Table 17. Global Respiratory Syncytial Virus Diagnostic Testing Sales Market Share in Value by Type (2025-2030) & (%)

Table 18. Global Respiratory Syncytial Virus Diagnostic Testing Sales Value by Application: 2019 VS 2023 VS 2030 (US$ Million)

Table 19. Global Respiratory Syncytial Virus Diagnostic Testing Sales Value by Application (2019-2024) & (US$ Million)

Table 20. Global Respiratory Syncytial Virus Diagnostic Testing Sales Value by Application (2025-2030) & (US$ Million)

Table 21. Global Respiratory Syncytial Virus Diagnostic Testing Sales Market Share in Value by Application (2019-2024) & (%)

Table 22. Global Respiratory Syncytial Virus Diagnostic Testing Sales Market Share in Value by Application (2025-2030) & (%)

Table 23. Global Respiratory Syncytial Virus Diagnostic Testing Sales Value by Region: 2019 VS 2023 VS 2030 (US$ Million)

Table 24. Global Respiratory Syncytial Virus Diagnostic Testing Sales Value by Region (2019-2024) & (US$ Million)

Table 25. Global Respiratory Syncytial Virus Diagnostic Testing Sales Value by Region (2025-2030) & (US$ Million)

Table 26. Global Respiratory Syncytial Virus Diagnostic Testing Sales Value by Region (2019-2024) & (%)

Table 27. Global Respiratory Syncytial Virus Diagnostic Testing Sales Value by Region (2025-2030) & (%)

Table 28. Key Countries/Regions Respiratory Syncytial Virus Diagnostic Testing Sales Value Growth Trends, (US$ Million): 2019 VS 2023 VS 2030

Table 29. Key Countries/Regions Respiratory Syncytial Virus Diagnostic Testing Sales Value, (2019-2024) & (US$ Million)

Table 30. Key Countries/Regions Respiratory Syncytial Virus Diagnostic Testing Sales Value, (2025-2030) & (US$ Million)

Table 31. F. Hoffmann-La Roche AG Basic Information List

Table 32. F. Hoffmann-La Roche AG Description and Business Overview

Table 33. F. Hoffmann-La Roche AG Respiratory Syncytial Virus Diagnostic Testing Products, Services and Solutions

Table 34. Revenue (US$ Million) in Respiratory Syncytial Virus Diagnostic Testing Business of F. Hoffmann-La Roche AG (2019-2024)

Table 35. F. Hoffmann-La Roche AG Recent Developments

Table 36. Abbott Basic Information List

Table 37. Abbott Description and Business Overview

Table 38. Abbott Respiratory Syncytial Virus Diagnostic Testing Products, Services and Solutions

Table 39. Revenue (US$ Million) in Respiratory Syncytial Virus Diagnostic Testing Business of Abbott (2019-2024)

Table 40. Abbott Recent Developments

Table 41. Thermo Fisher Scientific Basic Information List

Table 42. Thermo Fisher Scientific Description and Business Overview

Table 43. Thermo Fisher Scientific Respiratory Syncytial Virus Diagnostic Testing Products, Services and Solutions

Table 44. Revenue (US$ Million) in Respiratory Syncytial Virus Diagnostic Testing Business of Thermo Fisher Scientific (2019-2024)

Table 45. Thermo Fisher Scientific Recent Developments

Table 46. BD (Becton, Dickinson and Company) Basic Information List

Table 47. BD (Becton, Dickinson and Company) Description and Business Overview

Table 48. BD (Becton, Dickinson and Company) Respiratory Syncytial Virus Diagnostic Testing Products, Services and Solutions

Table 49. Revenue (US$ Million) in Respiratory Syncytial Virus Diagnostic Testing Business of BD (Becton, Dickinson and Company) (2019-2024)

Table 50. BD (Becton, Dickinson and Company) Recent Developments

Table 51. QuidelOrtho Corporation Basic Information List

Table 52. QuidelOrtho Corporation Description and Business Overview

Table 53. QuidelOrtho Corporation Respiratory Syncytial Virus Diagnostic Testing Products, Services and Solutions

Table 54. Revenue (US$ Million) in Respiratory Syncytial Virus Diagnostic Testing Business of QuidelOrtho Corporation (2019-2024)

Table 55. QuidelOrtho Corporation Recent Developments

Table 56. Hologic, Inc. Basic Information List

Table 57. Hologic, Inc. Description and Business Overview

Table 58. Hologic, Inc. Respiratory Syncytial Virus Diagnostic Testing Products, Services and Solutions

Table 59. Revenue (US$ Million) in Respiratory Syncytial Virus Diagnostic Testing Business of Hologic, Inc. (2019-2024)

Table 60. Hologic, Inc. Recent Developments

Table 61. Luminex Corporation Basic Information List

Table 62. Luminex Corporation Description and Business Overview

Table 63. Luminex Corporation Respiratory Syncytial Virus Diagnostic Testing Products, Services and Solutions

Table 64. Revenue (US$ Million) in Respiratory Syncytial Virus Diagnostic Testing Business of Luminex Corporation (2019-2024)

Table 65. Luminex Corporation Recent Developments

Table 66. Agilent Technologies, Inc. Basic Information List

Table 67. Agilent Technologies, Inc. Description and Business Overview

Table 68. Agilent Technologies, Inc. Respiratory Syncytial Virus Diagnostic Testing Products, Services and Solutions

Table 69. Revenue (US$ Million) in Respiratory Syncytial Virus Diagnostic Testing Business of Agilent Technologies, Inc. (2019-2024)

Table 70. Agilent Technologies, Inc. Recent Developments

Table 71. Cepheid (Danaher Corporation) Basic Information List

Table 72. Cepheid (Danaher Corporation) Description and Business Overview

Table 73. Cepheid (Danaher Corporation) Respiratory Syncytial Virus Diagnostic Testing Products, Services and Solutions

Table 74. Revenue (US$ Million) in Respiratory Syncytial Virus Diagnostic Testing Business of Cepheid (Danaher Corporation) (2019-2024)

Table 75. Cepheid (Danaher Corporation) Recent Developments

Table 76. DiaSorin S.p.A. Basic Information List

Table 77. DiaSorin S.p.A. Description and Business Overview

Table 78. DiaSorin S.p.A. Respiratory Syncytial Virus Diagnostic Testing Products, Services and Solutions

Table 79. Revenue (US$ Million) in Respiratory Syncytial Virus Diagnostic Testing Business of DiaSorin S.p.A. (2019-2024)

Table 80. DiaSorin S.p.A. Recent Developments

Table 81. Key Raw Materials Lists

Table 82. Raw Materials Key Suppliers Lists

Table 83. Respiratory Syncytial Virus Diagnostic Testing Downstream Customers

Table 84. Respiratory Syncytial Virus Diagnostic Testing Distributors List

Table 85. Research Programs/Design for This Report

Table 86. Key Data Information from Secondary Sources

Table 87. Key Data Information from Primary Sources

Table 88. Business Unit and Senior & Team Lead Analysts

List of Figures

Figure 1. Respiratory Syncytial Virus Diagnostic Testing Product Picture

Figure 2. Global Respiratory Syncytial Virus Diagnostic Testing Sales Value, 2019 VS 2023 VS 2030 (US$ Million)

Figure 3. Global Respiratory Syncytial Virus Diagnostic Testing Sales Value (2019-2030) & (US$ Million)

Figure 4. Respiratory Syncytial Virus Diagnostic Testing Report Years Considered

Figure 5. Global Respiratory Syncytial Virus Diagnostic Testing Players Revenue Ranking (2023) & (US$ Million)

Figure 6. The 5 and 10 Largest Manufacturers in the World: Market Share by Respiratory Syncytial Virus Diagnostic Testing Revenue in 2023

Figure 7. Respiratory Syncytial Virus Diagnostic Testing Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023

Figure 8. Antigen Detection Test Picture

Figure 9. Molecular Diagnostic Test Picture

Figure 10. Direct Fluorescent Antibody Test Picture

Figure 11. Diagnostic Imaging Picture

Figure 12. Others Picture

Figure 13. Global Respiratory Syncytial Virus Diagnostic Testing Sales Value by Type (2019 VS 2023 VS 2030) & (US$ Million)

Figure 14. Global Respiratory Syncytial Virus Diagnostic Testing Sales Value Market Share by Type, 2023 & 2030

Figure 15. Product Picture of Hospitals

Figure 16. Product Picture of Diagnostic Laboratories

Figure 17. Product Picture of Others

Figure 18. Global Respiratory Syncytial Virus Diagnostic Testing Sales Value by Application (2019 VS 2023 VS 2030) & (US$ Million)

Figure 19. Global Respiratory Syncytial Virus Diagnostic Testing Sales Value Market Share by Application, 2023 & 2030

Figure 20. North America Respiratory Syncytial Virus Diagnostic Testing Sales Value (2019-2030) & (US$ Million)

Figure 21. North America Respiratory Syncytial Virus Diagnostic Testing Sales Value by Country (%), 2023 VS 2030

Figure 22. Europe Respiratory Syncytial Virus Diagnostic Testing Sales Value (2019-2030) & (US$ Million)

Figure 23. Europe Respiratory Syncytial Virus Diagnostic Testing Sales Value by Country (%), 2023 VS 2030

Figure 24. Asia Pacific Respiratory Syncytial Virus Diagnostic Testing Sales Value (2019-2030) & (US$ Million)

Figure 25. Asia Pacific Respiratory Syncytial Virus Diagnostic Testing Sales Value by Country (%), 2023 VS 2030

Figure 26. South America Respiratory Syncytial Virus Diagnostic Testing Sales Value (2019-2030) & (US$ Million)

Figure 27. South America Respiratory Syncytial Virus Diagnostic Testing Sales Value by Country (%), 2023 VS 2030

Figure 28. Middle East & Africa Respiratory Syncytial Virus Diagnostic Testing Sales Value (2019-2030) & (US$ Million)

Figure 29. Middle East & Africa Respiratory Syncytial Virus Diagnostic Testing Sales Value by Country (%), 2023 VS 2030

Figure 30. Key Countries/Regions Respiratory Syncytial Virus Diagnostic Testing Sales Value (%), (2019-2030)

Figure 31. United States Respiratory Syncytial Virus Diagnostic Testing Sales Value, (2019-2030) & (US$ Million)

Figure 32. United States Respiratory Syncytial Virus Diagnostic Testing Sales Value by Type (%), 2023 VS 2030

Figure 33. United States Respiratory Syncytial Virus Diagnostic Testing Sales Value by Application (%), 2023 VS 2030

Figure 34. Europe Respiratory Syncytial Virus Diagnostic Testing Sales Value, (2019-2030) & (US$ Million)

Figure 35. Europe Respiratory Syncytial Virus Diagnostic Testing Sales Value by Type (%), 2023 VS 2030

Figure 36. Europe Respiratory Syncytial Virus Diagnostic Testing Sales Value by Application (%), 2023 VS 2030

Figure 37. China Respiratory Syncytial Virus Diagnostic Testing Sales Value, (2019-2030) & (US$ Million)

Figure 38. China Respiratory Syncytial Virus Diagnostic Testing Sales Value by Type (%), 2023 VS 2030

Figure 39. China Respiratory Syncytial Virus Diagnostic Testing Sales Value by Application (%), 2023 VS 2030

Figure 40. Japan Respiratory Syncytial Virus Diagnostic Testing Sales Value, (2019-2030) & (US$ Million)

Figure 41. Japan Respiratory Syncytial Virus Diagnostic Testing Sales Value by Type (%), 2023 VS 2030

Figure 42. Japan Respiratory Syncytial Virus Diagnostic Testing Sales Value by Application (%), 2023 VS 2030

Figure 43. South Korea Respiratory Syncytial Virus Diagnostic Testing Sales Value, (2019-2030) & (US$ Million)

Figure 44. South Korea Respiratory Syncytial Virus Diagnostic Testing Sales Value by Type (%), 2023 VS 2030

Figure 45. South Korea Respiratory Syncytial Virus Diagnostic Testing Sales Value by Application (%), 2023 VS 2030

Figure 46. Southeast Asia Respiratory Syncytial Virus Diagnostic Testing Sales Value, (2019-2030) & (US$ Million)

Figure 47. Southeast Asia Respiratory Syncytial Virus Diagnostic Testing Sales Value by Type (%), 2023 VS 2030

Figure 48. Southeast Asia Respiratory Syncytial Virus Diagnostic Testing Sales Value by Application (%), 2023 VS 2030

Figure 49. India Respiratory Syncytial Virus Diagnostic Testing Sales Value, (2019-2030) & (US$ Million)

Figure 50. India Respiratory Syncytial Virus Diagnostic Testing Sales Value by Type (%), 2023 VS 2030

Figure 51. India Respiratory Syncytial Virus Diagnostic Testing Sales Value by Application (%), 2023 VS 2030

Figure 52. Respiratory Syncytial Virus Diagnostic Testing Industrial Chain

Figure 53. Respiratory Syncytial Virus Diagnostic Testing Manufacturing Cost Structure

Figure 54. Channels of Distribution (Direct Sales, and Distribution)

Figure 55. Bottom-up and Top-down Approaches for This Report

Figure 56. Data Triangulation

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$3950

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$5925

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$7900

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

SIMILAR REPORTS

120 Pages

Type: Report

Code: QYRE-Auto-7S2745

Tue Oct 15 00:00:00 UTC 2024

Add to Cart

Measles Vaccine - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030

120 Pages

Type: Report

Code: QYRE-Auto-34D11827

Fri Oct 11 00:00:00 UTC 2024

Add to Cart

Vaccine Delivery Devices - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030

120 Pages

Type: Report

Code: QYRE-Auto-35Z7701

Thu Oct 10 00:00:00 UTC 2024

Add to Cart

Vaccine Freezers - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030

120 Pages

Type: Report

Code: QYRE-Auto-34W13373

Tue Oct 08 00:00:00 UTC 2024

Add to Cart

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions

Respiratory Syncytial Virus Diagnostic Testing - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030

Published Date: October 2024

Report Code: QYRE-Auto-10C13967

Respiratory Syncytial Virus Diagnostic Testing - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030

FEATURED COMPANIES

Respiratory Syncytial Virus Diagnostic Testing - Market Size

Respiratory Syncytial Virus Diagnostic Testing - Market

Report Scope

Scope of Respiratory Syncytial Virus Diagnostic Testing - Market Report

Chapter Outline

FAQ for this report

Who are the main players in the Respiratory Syncytial Virus Diagnostic Testing - Market report?

What are the Application segmentation covered in the Respiratory Syncytial Virus Diagnostic Testing - Market report?

What are the Type segmentation covered in the Respiratory Syncytial Virus Diagnostic Testing - Market report?

FEATURED COMPANIES

RELATED REPORTS